Welcome to the EU-project BAMOD

It has been known for centuries that the odour or smell of an individual is in some cases an indicator or a symptom of disease. The classic case of this is the sweet smell of a person suffering from diabetes resulting from the excessive amount of acetone emitted in the breath and through the skin.

The EU-project BAMOD focuses on the detection of lung and oesophageal cancer based on exhaled breath. Different analytical techniques are used for the analysis of breath samples: gas chromatography with mass spectrometric detection (GC-MS), selected-ion-flow-tube mass spectrometry (SIFT-MS) and proton-transfer-reaction mass spectrometry (PTR-MS), laser spectrometry and ion mobility spectrometry (IMS).

BAMOD: The acronym BAMOD stands for “Breath-gas analysis for molecular-oriented detection of minimal diseases”, based on the European Union 6th framework call LSH-2004-2.2.0-7 “Molecular-oriented detection and treatment of minimal disease”.